Onivyde irinotecan regulatory update

The European Commission approved an MAA from Shire for Onivyde in combination with 5-fluorouracil (5-FU) and leucovorin to treat metastatic pancreatic cancer in patients who progressed following gemcitabine-based therapy. Onivyde is nanoparticle liposome formulation of irinotecan...